In the context of adaptive immunity, the dysregulation of lipid metabolism in NAFLD has been associated with a selective loss of intrahepatic CD4+ T cells which further could lead to progression to HCC, highlighting a possible link between abnormal lipid metabolism and impaired anti-tumor immune surveillance. The gene discussed is CD4; the disease is neoplasm.